Take context from the input text and decide on the accurate relationship between 'Tabrecta' and 'Novartis' from the options provided.
Options: location of formation, chief executive officer, manufacturer, distributed by

Executing successful launches for both Monjuvi and Pemazyre, and we expect Tabrecta royalties to increase following the approvals and subsequent launches by Novartis in both the U.S. and Japan.
manufacturer